Teva-Lisinopril/Hctz (Type Z) 12.5 mg

Teva-Lisinopril/HCTZ (Type Z) 12.5 MG tablets combine lisinopril and hydrochlorothiazide for blood pressure management. This oral medication is designed to support cardiovascular health by promoting fluid balance and reducing blood pressure.

Teva-Lisinopril/HCTZ (Type Z) 12.5 MG tablets are commonly used for managing high blood pressure, often referred to as hypertension. The combination of lisinopril, an ACE inhibitor, and hydrochlorothiazide, a diuretic, works to lower blood pressure by relaxing blood vessels and promoting fluid excretion. This medication is typically prescribed for individuals who require both types of treatment to achieve optimal blood pressure control.

Common effects of Teva-Lisinopril/HCTZ (Type Z) 12.5 MG tablets may include dizziness, fatigue, and mild nausea. Some users might experience a dry cough, which is a known side effect of ACE inhibitors. It's important to monitor for signs of dehydration or electrolyte imbalances, as hydrochlorothiazide can increase urine output.

Teva-Lisinopril/HCTZ (Type Z) 12.5 MG tablets should be handled with care, especially for individuals with kidney or liver conditions. Regular monitoring of blood pressure and electrolyte levels is recommended. Avoid sudden changes in posture to prevent dizziness, and stay hydrated to support overall health.

Teva-Lisinopril/HCTZ (Type Z) 12.5 MG tablets may interact with certain medications, including nonsteroidal anti-inflammatory drugs (NSAIDs), potassium supplements, and other blood pressure medications. Alcohol consumption should be moderated, as it can enhance the effects of the medication. Always consult a healthcare provider before starting or stopping any medication.